SloMo2: Implementation, Effectiveness, and Cost-effectiveness Study
Recruiting
N/A
Interventional Study
Schizophrenia Spectrum and Other Psychotic Disorders
Affective Psychoses
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 150 (estimated)
- Sponsor
- King's College London · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Worries about harm from others (also known as paranoia) are common. Thinking fast or going on gut feelings is natural but can fuel these worries. For some, fast thinking and worries start to get in the way of life. Cognitive behaviour therapy for psychosis (CBTp) is the recommended talking therapy. However, only a minority of people can access CBTp due to limited resources, and even when available…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Meet criteria for ICD-10 psychosis diagnoses (F20-29, F30-39)
* Seeking therapy for paranoia
* In contact with secondary care mental health services
* Capacity to provide informed consent to engage in therapy
Exclusion Criteria:
* Acute risk of harm to self or others
* Unabl…
Contacts